Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Abbv crawled time : 13:30 save search
AbbVie to Present at the TD Cowen 44th Annual Health Care Conference
Published: 2024-02-27 (Crawled : 13:30) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.13%
H: 0.0%
C: 0.0%
conference abbvie health care
U.S. Food and Drug Administration (FDA) Grants Priority Review of Epcoritamab (EPKINLY®) for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma (FL)
Published: 2024-02-27 (Crawled : 13:30) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.13%
H: 0.0%
C: 0.0%
epkinly drug review food grants
AbbVie Unveils New Data from Robust Gastroenterology Portfolio at the 19th Congress of European Crohn's and Colitis Organisation (ECCO)
Published: 2024-02-19 (Crawled : 13:30) - prnewswire.com
IMGN | News | $31.23 0.03% 49M
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
| Email alert
Add to watchlist
abbvie congress
Ironwood Pharmaceuticals Reports Third Quarter 2023 Results
Published: 2023-11-09 (Crawled : 13:30) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -1.81%
H: 0.43%
C: -2.1%
IRWD | $8.11 -2.41% -2.47% 1.9M
|
Health Technology
|
| O: 2.93%
H: 4.37%
C: 0.21%
pharmaceuticals ironwood results
Lupus Therapeutics Partners with AbbVie on Clinical Trial Recruitment Efforts in SLE Through LuCIN Lupus Clinical Trial Network
Published: 2023-10-24 (Crawled : 13:30) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
abbvie lupus network trial therapeutics
Ironwood Releases New IBS-C and CIC Data at the American College of Gastroenterology 2023 Annual Scientific Meeting
Published: 2023-10-23 (Crawled : 13:30) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.05%
H: 0.18%
C: -0.98%
IRWD | $8.11 -2.41% -2.47% 1.9M
|
Health Technology
|
| O: -0.87%
H: 0.87%
C: -1.64%
ironwood meeting
AbbVie Showcases Breadth and Depth of Research in Crohn's Disease and Ulcerative Colitis at UEG Week 2023
Published: 2023-10-10 (Crawled : 13:30) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: 0.0%
disease abbvie research week
AbbVie and Scripps Research Announce Collaboration to Develop Antiviral Treatments for COVID-19
Published: 2022-03-15 (Crawled : 13:30) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.11%
H: 2.74%
C: 2.38%
covid-19 treatment research covid collaboration antiviral
Therapeutics for Women's Health - A Comprehensive Industry Assessment Highlighting the Key Opportunities, Pricing & Reimbursement, Players, and Strategic Recommendations - Forecast to 2026
Published: 2022-03-11 (Crawled : 13:30) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 2.1%
H: 0.0%
C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -2.32%
H: 2.3%
C: 0.22%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.63%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.22%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 0.98%
H: 0.0%
C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.66%
H: 0.0%
C: 0.0%
health therapeutics women
AbbVie Announces Positive Phase 3 Atogepant (QULIPTA™) Data for the Preventive Treatment of Chronic Migraine
Published: 2022-03-10 (Crawled : 13:30) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: 0.0%
treatment pos migraine positive phase 3
Dermatologicals Market to Reach $59.30 Bn, Globally, by 2030 at 11.50% CAGR: AMR
Published: 2022-02-21 (Crawled : 13:30) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
| Email alert
Add to watchlist
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
| Email alert
Add to watchlist
als dermatological derm
Ironwood Pharmaceuticals Provides Update on FY 2021 Financial Guidance and Announces FY 2022 Financial Guidance
Published: 2022-01-10 (Crawled : 13:30) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
IRWD | $8.11 -2.41% -2.47% 1.9M
|
Health Technology
|
| O: -3.79%
H: 4.65%
C: 4.29%
AbbVie Submits Application for Risankizumab (SKYRIZI®) in Moderate to Severe Crohn's Disease to European Medicines Agency (EMA)
Published: 2021-11-30 (Crawled : 13:30) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
ema europe application disease risankizumab
AbbVie to Present at the Evercore ISI Conference
Published: 2021-11-23 (Crawled : 13:30) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: 0.0%
conference
Junshi Biosciences and Coherus Announce Toripalimab Granted Orphan Drug Designation in the United States for Esophageal Cancer
Published: 2021-11-15 (Crawled : 13:30) - globenewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.34%
H: 0.73%
C: -0.09%
CHRS | $2.03 -6.88% -7.39% 720K
|
Health Technology
|
| O: 1.46%
H: 1.81%
C: 0.75%
orphan drug cancer drug granted designation
Coherus and Junshi Biosciences Announce Toripalimab Granted Orphan Drug Designation in the United States for Esophageal Cancer
Published: 2021-11-15 (Crawled : 13:30) - globenewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.34%
H: 0.73%
C: -0.09%
CHRS | $2.03 -6.88% -7.39% 720K
|
Health Technology
|
| O: 1.46%
H: 1.81%
C: 0.75%
orphan drug cancer drug granted designation
Bicycle Therapeutics Appoints Jose-Carlos Gutierrez-Ramos, Ph.D., to its Board of Directors
Published: 2021-03-18 (Crawled : 13:30) - biospace.com/
DHR | $250.41 -1.07% -0.72% 3.3M
|
Health Technology
|
| O: 0.02%
H: 1.94%
C: 0.82%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.99%
H: 0.95%
C: -0.22%
SYBX | $1.9 -0.52% -0.53% 19K
|
Health Technology
|
| O: 7.13%
H: 4.96%
C: -10.23%
BCYC | $22.7 0.09% 0.09% 520K
|
Health Technology
|
| O: 1.13%
H: 2.98%
C: -6.17%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -1.54%
H: 2.76%
C: 1.63%
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.